The Association Between Beta2 Adrenergic Receptor Polymorphism and Coronary Microvascular Dysfunction

The Association Between Beta2 Adrenergic Receptor Polymorphism and Coronary Microvascular Dysfunction - The Association Between ADRB2 Polymorphism and Coronary Microvascular Dysfunction

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000043834

Enrollment

800

Registered

2021-04-05

Start date

2021-01-11

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary microvascular dysfunction

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: The patients with coronary microvascular dysfunction. The patients with denied coronary artery disease (as control group). The cases in medical checkup without cardiovascular diseases (as control group).

Exclusion criteria

Exclusion criteria: Other than those above.

Design outcomes

Primary

Measure	Time frame
Beta2 adrenergic receptor gene polymorphism was associated with coronary microvascular dysfunction.	—

Countries

Japan

Contacts

Public ContactSatoru SUZUKI

Graduate School of Medical Science,Kumamoto University Department of Cardiovascular Medicine

s-satoru@kumamoto-u.ac.jp0963735175

Outcome results